|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -50.00% |
|
-50.00% | -87.50% |
| 05-29 | Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 05-29 | Stemtech Corporation Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 414K 357K 329K 308K 578K 39.6M 587K 3.9M 1.52M 19.09M 1.55M 1.52M 66.18M | P/E Ratio 2024 |
-1.46x | P/E Ratio 2025 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 5.18M 4.48M 4.12M 3.86M 7.24M 496M 7.35M 48.83M 19M 239M 19.45M 19.03M 829M | EV / Sales 2024 |
2.08x | EV / Sales 2025 | 1.78x |
| Free-Float |
87.98% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -50.00% | ||
| 1 week | -50.00% | ||
| Current month | -50.00% | ||
| 1 month | -50.00% | ||
| 3 months | -66.67% | ||
| 6 months | -94.12% | ||
| Current year | -87.50% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.1 | |
| 5 years | 0 | 11.5 | |
| 10 years | 0 | 11.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Arnold
CEO | Chief Executive Officer | 75 | 19/08/2021 |
| Director of Finance/CFO | 41 | 15/04/2025 | |
John Meyer
PSD | President | 72 | 19/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Arnold
CHM | Chairman | 75 | 19/08/2021 |
John Meyer
BRD | Director/Board Member | 72 | 19/08/2021 |
Benjamin Kaplan
BRD | Director/Board Member | 54 | 17/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/06/25 | Sell | Director | 1,000,000 | 0.7421% | ||
| 26/07/24 | Other | Chief Executive Officer | 25,000 | 0.0239% | ||
| 19/04/24 | Mindshare Holdings, Inc.
| Sell | Company | 25,000 | 0.0239% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -50.00% | -50.00% | -99.67% | -99.83% | 414K | ||
| +1.63% | -1.21% | +16.80% | -18.09% | 61.21B | ||
| +2.50% | +7.58% | +64.44% | +216.37% | 58.15B | ||
| -0.92% | +28.60% | +28.60% | +28.60% | 39.54B | ||
| +4.16% | +16.25% | -56.08% | -64.88% | 35.08B | ||
| +2.94% | +2.04% | +47.58% | -35.26% | 28.68B | ||
| +2.32% | +10.05% | +53.89% | +76.65% | 21.06B | ||
| +7.94% | +1.18% | +79.34% | -59.73% | 18.25B | ||
| -1.88% | -5.07% | -10.05% | +93.76% | 16.49B | ||
| +0.78% | +0.78% | +49.83% | +98.01% | 15.87B | ||
| Average | -3.05% | +1.13% | +17.47% | +23.56% | 29.43B | |
| Weighted average by Cap. | +2.09% | +1.44% | +28.92% | +43.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.05M 4.37M 4.02M 3.77M 7.06M 484M 7.17M 47.64M 18.53M 233M 18.97M 18.56M 809M | 2.88M 2.49M 2.29M 2.14M 4.02M 275M 4.08M 27.11M 10.55M 133M 10.8M 10.56M 460M |
| Net income | -3.77M -3.26M -3M -2.81M -5.27M -361M -5.35M -35.53M -13.82M -174M -14.15M -13.85M -603M | -4.05M -3.5M -3.22M -3.02M -5.65M -387M -5.74M -38.15M -14.84M -187M -15.19M -14.86M -648M |
| Net Debt | 4.23M 3.66M 3.37M 3.16M 5.91M 405M 6.01M 39.91M 15.52M 195M 15.89M 15.55M 677M | 4.77M 4.12M 3.79M 3.55M 6.66M 456M 6.76M 44.94M 17.48M 220M 17.89M 17.51M 763M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/26 | 0.000100 $ | -50.00% | 2,442,186 |
| 10/06/26 | 0.000200 $ | +29.03% | 1,108,001 |
| 09/06/26 | 0.000155 $ | -22.50% | 452,313 |
| 08/06/26 | 0.000200 $ | 0.00% | 545,084 |
| 05/06/26 | 0.000200 $ | 0.00% | 389,944 |
- Stock Market
- Stocks
- STEK Stock
Select your edition
All financial news and data tailored to specific country editions
















